A professor at the University of Tennessee has been given a grant to continue to study the development of drugs to fight the late stages of breast cancer.
Murali Yallapu, an assistant professor in the college of pharmacy at UT, got a $439,818 grant from the National Institutes of Health to continue his research.
Dr. Yallapu will not be working alone though.
He has three other members with him on his research team including Prashanth Kumar, PHD, Pallabita Chowdhury and Elhami Hatami, according to UT's Health Science Center.
The team will have enough funding for three years of research. They will look into the ability to sensitize resistant cells.
They will use Dr. Murali's magnetic nano-particle delivery system to be able to find those the tumor cells that are resistant to drugs.
The Food and Drug administration hasn't yet approved a specifically targeted plan for the late stages of breast cancer.
This means that Dr. Murali and his team would be at the forefront of changing the way that doctors address late stages of breast cancer with his research.
